Lida Daidaihua
| Availability: | Yes |
| Delivery: | 4-7 days |
| Payment: | credit cards, bank transfer |
 |
Information based on official AEMPS alerts (Illegal medicines alert 7/2013 and November 2020 alert), AESAN, the US FDA and the Australian TGA.
If you have searched for Lida Daidaihua for weight loss, or already have it at home, this information affects you directly. This is not a marketing article — it is an honest explanation of what this product is, what it really contains, and why three international regulatory agencies have declared it dangerous.
Important safety notice
The AEMPS (Spanish Agency for Medicines and Medical Devices) has issued official alerts about Li Da Daidaihua in 2013 and 2020, classifying it as an illegal medicinal product dangerous to health. Cases of fatal adverse reactions have been registered. This page explains why, what it really contains, and what you should do if you have this product at home.
What Lida Daidaihua Claims to Be
Lida Daidaihua is marketed as a natural plant-based slimming product of Chinese origin, in 60mg capsules. Its labelling indicates herbal components — mainly Sida Cordifolia extract — and promises weight loss with minimal side effects. This description is false in one critical respect.
What It Really Contains — Undeclared Sibutramine
Laboratory analyses by the AEMPS and other regulatory agencies have confirmed that Lida Daidaihua contains sibutramine — a pharmaceutical active ingredient that does not appear declared on the product label.
| Aspect | What the label says | What it really contains |
|---|---|---|
| Composition | Natural herbal extracts | Sibutramine (undeclared pharmaceutical active ingredient) |
| Classification | Natural herbal supplement | Illegal medicinal product — classified by AEMPS |
| Legal status in EU | Sold as natural product | Banned — sibutramine not authorised in the EU since 2010 |
| Side effects | «Rare, natural formula» | Arrhythmias, ischaemic heart disease, stroke, death |
What Sibutramine Is and Why It Was Banned
Sibutramine was a prescription drug for obesity that worked as an appetite suppressant by acting on the central nervous system. It was effective for weight loss, but long-term clinical trials revealed an unacceptable cardiovascular risk profile.
Why it was withdrawn in 2010
The SCOUT study (Sibutramine Cardiovascular Outcomes Trial) showed that high cardiovascular risk patients taking sibutramine had a 16% higher risk of non-fatal myocardial infarction or stroke. The EMA withdrew authorisation in January 2010. The AEMPS suspended it in Spain the same month.
What it does to the body
- Increases heart rate
- Raises blood pressure
- Cardiac arrhythmias
- Ischaemic heart disease
- Cerebrovascular accident
- Higher risk in people with hypertension, pre-existing heart disease or diabetes
The problem with Lida Daidaihua is that the sibutramine it contains is not declared on the label. Those who take it do not know they are taking a high-risk cardiovascular drug. They cannot consult their doctor because they believe it is a herbal product. They cannot adjust other medications they may be taking. And they cannot make an informed decision about whether their health profile makes them suitable for that active ingredient.
Timeline of Official Alerts
Who Is at Greatest Risk
High blood pressure
Sibutramine raises blood pressure — dangerously so in people already hypertensive
Pre-existing heart disease
Arrhythmias and heart attack — risk multiplied in people with cardiac history
Type 2 diabetes
Already elevated cardiovascular risk profile — sibutramine makes it worse
Pregnancy
Effect on the foetus unknown — exposure to sibutramine during pregnancy is unacceptable
Other cardiovascular drugs
Sibutramine interacts with antidepressants, triptans, opioids — risk of serotonin syndrome
Under 16 years of age
Safety not established in minors — unknown risk
What to Do If You Have Lida Daidaihua at Home
AEMPS and AESAN recommendations:
- Stop taking it immediately — do not finish the pack even if you think it is working
- Do not throw it in household waste — take it to the SIGRE point at your pharmacy (medicines container)
- If you experienced palpitations, chest pressure, severe headache or difficulty breathing while taking it — see your doctor or go to A&E
- If you bought it online — do not provide further details to that website; it may be fraudulent
- Tell others in your circle who may be taking it
Safe Approved Alternatives for Weight Control
Note on other «natural» slimming pills: The online market is full of products similar to Li Da Daidaihua sold as «herbal» or «natural» but containing undeclared pharmaceutical active ingredients. Before buying any slimming product online, verify it appears in the CIMA (AEMPS Online Medicine Information Centre) or consult your doctor or pharmacist.
Frequently Asked Questions
I have taken Lida Daidaihua and nothing happened to me — does that mean it's safe? No. Sibutramine may not produce immediate effects in healthy people without cardiovascular risk factors, but continued use progressively increases the risk of cardiac events. The fatal case registered by the AEMPS was in a person who also did not expect to have a problem.
The version I bought says it's different from the one the AEMPS warned about — is it the same? The product appears under variant names («Li Da Plus», «Li Da Strong», «New Lida», etc.) but the composition is the same. Authorities have detected sibutramine in multiple versions and presentations of the product.
If sibutramine was an authorised drug before 2010, why is it so dangerous in Lida Daidaihua? When it was authorised, it was prescribed under medical supervision, in controlled doses, excluding high cardiovascular risk patients, and with ongoing monitoring. In Lida Daidaihua it is taken without knowing it is being taken, without supervision, without exclusion of at-risk patients and without a verified controlled dose.
Official Sources
- AEMPS — Illegal medicines alert 7/2013: Li Da Daidaihua
- AEMPS — Informational note November 2020: death linked to Li Da Daidaihua
- AESAN — Food safety notice November 2020
- FDA — Public Notification: Li Da Daidaihua Plus, December 2020
- EMA — Suspension of sibutramine authorisation (Reductil), January 2010
This page is for informational and public health purposes only. If you have concerns about your health after consuming this product, consult your doctor or call your regional health emergency line.
